Clear Street’s Century Therapeutics IPSC Stock Holding History

Clear Street’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,100	Closed	-$3.13K	–	588
2024 Q4	$3.13K	Buy	+3,100	New	+$4.22K	﹤0.01%	438

Other funds holding IPSC

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Clear Street's IPSC Position: Q1 2025 in Review

Clear Street sold out of Century Therapeutics (IPSC) in Q1 2025, closing a stake of 3,100 shares — an estimated $3.13K sold.

Clear Street first reported a position in IPSC in Q4 2024 and held it in 1 quarter. The position peaked at $3.13K in Q4 2024. 70 funds tracked by Wall St. Rank hold IPSC as of Q1 2025.

Clear Street reported no remaining Century Therapeutics position as of Q1 2025 after selling out during the quarter.
Clear Street sold 3,100 Century Therapeutics shares in Q1 2025, an estimated $3.13K.
Clear Street first reported a position in Century Therapeutics in Q4 2024 and held it in 1 quarter.
Clear Street's Century Therapeutics position peaked at $3.13K in Q4 2024.
70 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2025.

Based on Clear Street's 13F filing for Q1 2025, filed 15 May 2025.